Medical research

Recovery of sensory function by stem cell transplants

New research from Uppsala University shows promising progress in the use of stem cells for treatment of spinal cord injury. The results, which are published in the scientific journal Scientific Reports, show that human stem ...

Alzheimer's disease & dementia

Looking for origins of Alzheimer's disease to find a treatment

Six or so years ago, Frank Longo, MD, PhD, Stanford's chair of neurology and neurological sciences, was optimistic that a treatment for Alzheimer's disease was on its way. More than a decade earlier, pharmaceutical companies ...

Genetics

Scientists shed new light on nerve cell growth

Amidst the astounding complexity of the billions of nerve cells and trillions of synaptic connections in the brain, how do nerve cells decide how far to grow or how many connections to build? How do they coordinate these ...

Neuroscience

Spinal nerve connections develop using simple rules

(Medical Xpress)—Repairing spinal injuries with stem cells may be a step closer thanks to scientists at the Universities of Bristol and Plymouth. A new study, published today in the Journal of Neuroscience, employed novel ...

Neuroscience

To live and learn: Making memories has to be a speedy business

The brain is plastic - adapting to the hundreds of experiences in our daily lives by reorganizing pathways and making new connections between nerve cells. This plasticity requires that memories of new information and experiences ...

Neuroscience

How visual attention affects the brain

New work at the University of California, Davis, shows for the first time how visual attention affects activity in specific brain cells. The paper, published June 26 in the journal Nature, shows that attention increases the ...

Alzheimer's disease & dementia

New drug reverses loss of brain connections in Alzheimer's disease

The first experimental drug to boost brain synapses lost in Alzheimer's disease has been developed by researchers at Sanford-Burnham Medical Research Institute. The drug, called NitroMemantine, combines two FDA-approved medicines ...

page 2 from 4